Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 5/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 9/20 | 0.43 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.43 |
| ▸ | GSK3B | P49841 | 7/20 | 0.43 |
| ▸ | FGFR4 | P22455 | 3/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
| ▸ | WNT1 | P04628 | 3/20 | 0.41 |
| ▸ | ABL2 | P42684 | 1/20 | 0.41 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.41 |
| ▸ | BCR | P11274 | 2/20 | 0.41 |
| ▸ | CLK2 | P49760 | 1/20 | 0.40 |
| ▸ | CLK3 | P49761 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20214778 | 0.91 | ABL1 (0.52) | ABL1DYRK1AMKNK2GSK3BFGFR4 | |
| SCHEMBL21350972 | 0.89 | ABL1 (0.42) | ABL1DYRK1AMKNK2FGFR4CDK8 | |
| SCHEMBL29614814 | 0.88 | ABL1 (0.49) | ABL1DYRK1AMKNK2FGFR4CDK8 | |
| SCHEMBL19307233 | 0.88 | ABL1 (0.49) | ABL1DYRK1AMKNK2FGFR4CDK8 | |
| SCHEMBL20214661 | 0.83 | ABL1 (0.46) | ABL1MKNK2FGFR4CDK8ABL2 | |
| SCHEMBL23732874 | 0.81 | ABL1 (0.44) | ABL1MKNK2FGFR4CDK8ABL2 | |
| SCHEMBL21351228 | 0.81 | ABL1 (0.42) | ABL1MKNK2FGFR4CDK8ABL2 | |
| SCHEMBL20227767 | 0.80 | ABL1 (0.46) | ABL1MKNK2FGFR4CDK8ABL2 | |
| SCHEMBL20227766 | 0.79 | ABL1 (0.46) | ABL1MKNK2FGFR4CDK8ABL2 | |
| SCHEMBL20214708 | 0.79 | ABL1 (0.45) | ABL1MKNK2FGFR4CDK8ABL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018102751-A1 | IRE1 SMALL MOLECULE INHIBITORS | QUENTIS THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |